What is Revo Squared?
Revo Squared operates at the intersection of veterinary medicine and advanced diagnostic technology. The company specializes in developing high-precision diagnostic products, including the TRUFORMA, TRUVIEW, and VETGuardian PLUS platforms, which are engineered to optimize clinical workflows and improve patient outcomes. By integrating cloud-based data analytics with hardware, Revo Squared provides veterinary professionals with the tools necessary for real-time monitoring and accurate diagnostic imaging. This integrated approach addresses the growing demand for efficiency in veterinary hospitals, positioning the firm as a critical infrastructure provider in the animal healthcare market.
How much funding has Revo Squared raised?
Revo Squared has raised a total of $52K across 1 funding round:
Debt
$52K
Debt (2021): $52K with participation from PPP
Key Investors in Revo Squared
PPP
Public-Private Partnership
What's next for Revo Squared?
With the recent infusion of capital, Revo Squared is expected to focus on scaling its operational capacity and expanding its footprint in the veterinary diagnostic market. The strategic deployment of these funds will likely prioritize the enhancement of its cloud-based diagnostic ecosystem and the broader distribution of its core product suite. As the company transitions through its current growth phase, the focus will remain on maintaining technological superiority while capturing a larger share of the veterinary diagnostic imaging and monitoring segment. Future developments will likely involve further integration of AI-driven diagnostic insights to support clinical decision-making.
See full Revo Squared company page
